Abstract
A controlled double-blind trial of amitriptyline at two dosage levels (75 and 150 mg/day), amylobarbitone (150 mg/day), and an inert substance for a period of four weeks was conducted on four matched groups of women attending their general practitioners and suffering from a depressive illness. Improvement at 7 and 28 days was noted on several measures of depression and anxiety in all treatment groups. Of these treatments amitriptyline 150 mg/day was the most consistent in relieving depression and anxiety. Troublesome side effects were equally distributed among the four treatments.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Carroll B. J., Mowbray R. M., Davies B. Sequential comparison of L-tryptophan with E.C.T. in severe depression. Lancet. 1970 May 9;1(7654):967–969. doi: 10.1016/s0140-6736(70)91096-2. [DOI] [PubMed] [Google Scholar]
- Fielding J. M., Mowbray R. M., Davies B. A preliminary controlled study of doxepin ("Sinequan") as an antianxiety drug. Med J Aust. 1969 Oct 25;2(17):851–852. doi: 10.5694/j.1326-5377.1969.tb107459.x. [DOI] [PubMed] [Google Scholar]
- Jones I. H. Riboflavine as an indicator of drug taking behaviour. Med J Aust. 1967 Feb 4;1(5):202–204. doi: 10.5694/j.1326-5377.1967.tb21152.x. [DOI] [PubMed] [Google Scholar]
- Leyburn P. A critical look at antidepressant drug trials. Lancet. 1967 Nov 25;2(7526):1135–1138. doi: 10.1016/s0140-6736(67)90635-6. [DOI] [PubMed] [Google Scholar]
- Rickels K., Gordon P. E., Jenkins B. W., Perloff M., Sachs T., Stepansky W. Drug treatment in depressive illness. Dis Nerv Syst. 1970 Jan;31(1):30–42. [PubMed] [Google Scholar]
- ZUNG W. W. A SELF-RATING DEPRESSION SCALE. Arch Gen Psychiatry. 1965 Jan;12:63–70. doi: 10.1001/archpsyc.1965.01720310065008. [DOI] [PubMed] [Google Scholar]